then classified qualitatively as normal or other based on the color tone of reaction mixture.
In the present paper, a simple and quantitative screening method biotinidase deficiency is described with a modification of the above method, the results of a pilot screening conducted in Sapporo City are described. the for and
MATERIALS AND METHODS
Specimens. Newborn and infant specimens were blood impregnated filter papers which were sent to us for the Guthrie test. Other specimens were prepared by dripping each adult blood onto the Guthrie filter paper and drying up in air for several hours. All specimens were stored at 4°C, unless otherwise noted.
Sampling. Dried, blood-saturated discs (3 mm diameter) were punched out from the filter papers.
Reagents. B-PAB was synthesized by the method of Wolf et al. (1983) . Biotinyl-Nhydroxysuccinimide was purchased from Polysciences Inc. (Warrington, PA, USA). PAB, N-1-naphtylethylenediamine dihydrochloride, ammonium sulfamate and trichloroacetic acid (TCA) were obtained from Kanto Chemical Co. (Tokyo) ; sodium nitrite from Nakarai Chemicals Ltd. (Kyoto).
Apparatus. An Inter Med microplate-reader, Immno Reader NJ-2000 equipped with a microcomputer system, was used.
Procedures. To each disc in a 96-well, U-bottomed microplate, 30 pl of the substrate solution containing 250pmole of B-PAB, 50 mmole of phosphate buffer (pH 6.0) and 5 mmole of EDTA per liter was added. The microplate was covered and incubated without shaking for 16 hr at 37°C. The reaction was stopped by adding 50 pl of 1.84 M TCA and hemoglobin denaturation was completed by standing for 10 min. Fifty p1-portions of the transparent reaction solution were transferred easily to a flat-bottomed microplate by use of a multichannel micropipette.
For the coupling reaction, 50 pl of each of the following reagents was added sequentially at 3 min intervals : 14.5 mM sodium nitrite, 43.8 mM ammonium sulfamate, and 3.86 mM N-1-naphthylethylenediamine dihydrochloride. After 10 min, the absorbance was measured at 540 nm. The biotinidase activity was calculated using a PAB calibration curve, which was prepared as follows : to a U-bottomed microplate well, 30 p1 of PAB solution containing 50 to 150 pmole of PAB per liter in the same medium as the substrate solution, without B-PAB, were added. Subsequent operations were identical to those described above without the incubation step. Samples which showed abnormal activity were detected by a statistical analysis in each assay. existed between the absorbance and the incubation time up to 16 hr. We used a 16 hr incubation for routine analyses, but if necessary to determine more exact activity, the incubation time can be fixed at 6 hr in the middle range of the linear relationship.
RESULTS AND DISCUSSION
pH of the substrate solution Biotinidase had maximal activity in the pH range of 5.2 to 6.2 for B-PAB (Fig. 2) , but pH around 6.0 is preferable for the assay because the solubility of B-PAB decreases with decreasing pH.
Enzyme amounts A series of whole blood containing various amounts of biotinidase was prepared by replacing varied portions of the plasma with the same volume of saline. Biotinidase activity in dried blood spot obtained from this series was measured. A linear relationship was found between the activity and plasma content (Fig. 3) .
Color development
The coloration reached a plateau within 2 min after the addition of the final reagent and did not change even after standing overnight. On the other hand, in the original method (Heard et al. 1984 ), the color intensity should be read within 30 min because of gradual disappearance of the color. This is due to the adsorp- Color development was measured for various times of incubation at 37°C using a blood disc.
Each point represents the mean of 8 normal samples. Each point represents the mean of 2 normal samples.
tion of the azo-dye on the coexisting denatured proteins.
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Interference As the color development occurs in the presence of a free primary aromatic amino group, some therapeutic drugs in routin samples might interfere with the assay. Heard et al. (1984) investigated the effects of sulfonamides and other therapeutic drugs on the biotinidase assay and demonstrated that sulfonamides gave purple color in the absence of B-PAB, but the other drugs did not interfere with the color development at their concentrations which greatly exceeded the expected concentrations in blood. Our observations supported this conclusion. No increase in mean and maximum adsorbance was detected in the group of neonates (n = 56) who were being treated with therapeutic drugs at the time of blood sampling. Furthermore, there was no coloration in the B-PAB free assay of the samples (n=23) showing high absorbance (more than 0.35) in the routine assays.
Reproducibility
The intea-assay CVs were in the range of 2.8 to 3.2% for PAB solutions and 5.1 to 8.0% for dried blood spots, and the inter-assay CVs were in the range of 3.3 to 4.7% for PAB solutions and 6.4 to 8.0% for dried blood spots ( Table 1 ). The CV for between blood spots obtained from the same blood samples was 6.4% (n = 4).
Correlation between activities in serum and dried blood spot As shown in Table 2 , the biotinidase activity in dried blood spot determined by this method was well correlated to that in serum, which was measured by the method of Wolf et al. (1983 (Fig. 4) . The activity was rapidly decreased during storage at 25 and 37°C, especially in the first 7 days, while it was fairly stable at -20°C even after 30 days. Consequently routine samples, which are stored at 4°C and tested within 7 days after collection, may lose some of the enzyme activity before assay. Nevertheless, the determined value will be accurate enough to detect positive samples in routin screening, if each sample is kept under similar conditions.
Application to the screening During a 1-year pilot study (Sep. 1985 -Aug. 1986 ), Sapporo City were screened using this method. The normal neonates (n = 7,910) was normally distributed After the storage of dried blood spot for indicated times at different temperatures, biotinidase activity was determined for 6 hr incubation at 3TC. The activity for each day was plotted as the the percentage of the initial activity.
Each point represents the mean of 6 normal samples.
3.05 + 0.68 pmole/min/disc. If the activity was less than 1.0 pmole/min/disc, the measurements were repeated on additional discs taken from the original filter paper, and if the activity was still below 0.6 pmole/min/disc or the absorbance was below 0.05, another filter paper sample was requested. Repeat measurements of 38 samples (0.20%) were made, and another sample was requested of six cases (0.03%). All of the recall results were normal, and therefore, no infants with biotinidase deficiency have been identified as yet. The incidence of biotinidase deficiency was estimated to be 1 in 41,000 newborns (Wolf et al. 1985) . As no such figure has been reported in Japan up to now, more extensive screening should be carried out. Heard et al. (1986) pointed out some possible factors to explain the abnormalities appearing on the initial filter paper samples, but they did not elaborate on those in the case of repeat samples taken from the same infant. The factors include improper handling of the samples such as high temperature conditions due to poorly controled air conditioning and, as we experienced, incomplete drying of the blood spot during collection, which will cause the considerable loss of biotinidase activity along with abnormal results of the Beutler test. Another factor to be considered is immaturity of biotinidase development. Heard et al. (1986) demonstrated that the mean biotinidase activity in serum of neonates was 53% of that of normal adults, and that the activity was positively correlated with gestational age. This idea is also supported by our findings that the mean activity of neonates was 79% of that of 1-month-old infants and 61% of that normal adults, but no significant differences were observed between low birth weight neonates and premature neonates (Table 3) . A third explanation for the abnormalities may be the presence of impaired liver functions, as we encountered in a 1-month-old infant with a hepatic disease, who showed low biotinidase activity (0.34 pmole/min/disc).
In this case, subsequent filter papers and serum assays revealed no biotinidase deficiency.
In conclusion, the proposed method proved to be sufficiently accurate and 
